Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Recommendation of “Buy” from Brokerages
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has earned an average rating of “Buy” from the ten ratings firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to the […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has earned an average rating of “Buy” from the ten ratings firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to the […]
-logo-1200x675.gif&w=240&h=240&zc=2){kind=logo}
